Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Addiction Biology|October 16, 2008
Stress, alcohol and drug interaction: an update of human researchMagdalena Uhart, Gary S Wand
Alcohol Research : Current Reviews|April 16, 2013
Clinical laboratory stressors used to study alcohol-stress relationshipsSuzanne Thomas, Amy K Bacon, Rajita Sinha, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 2006
Hormonal responses to psychological stress and family history of alcoholismMagdalena Uhart, Lynn Oswald, Mary E McCaul, et al.
Psychoneuroendocrinology|December 18, 2007
Whites have a more robust hypothalamic-pituitary-adrenal axis response to a psychological stressor than blacksRachel Y Chong, Magdalena Uhart, Mary E McCaul, et al.
Psychoneuroendocrinology|April 18, 2006
Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivityMagdalena Uhart, Rachel Y Chong, Lynn Oswald, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stressRachel Y Chong, Lynn Oswald, Xiaoju Yang, et al.
Addiction Biology|April 17, 2012
GABRA2 markers moderate the subjective effects of alcoholMagdalena Uhart, Elise M Weerts, Mary E McCaul, et al.
Pain|December 17, 2008
Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin painClaudia M Campbell, Robert R Edwards, Cheryl Carmona, et al.
The American Journal of Cardiology|August 29, 2017
Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes MellitusNaveed Sattar, Peter P Toth, Dirk J Blom, et al.
Circulation|March 3, 2017
Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension StudiesPeter P Toth, Olivier Descamps, Jacques Genest, et al.
Pageof 2